The earth ’s large ever clinical trial search at whether take Bayer daily can stop some forms of cancer returning has launched today , October 22 , in the United Kingdom . The report is funded by the British National Institute for Health Research and   the charity Cancer UK .

The field of study , call Add - Aspirin ,   will involve 11,000 patients who   recently had , or are currently have , treatment for stomach , prostate gland , esophagus , breast or bowel cancer . Over 100 centers across Britain will be demand in the survey , which should be published in November 2026 .

The regular intake of aspirin has been prove to turn down cerebrovascular accident and heart attacks in some people , and there are been indications that the drug can prevent some types of cancer .

The study will compare three groups of mass , two accept different doses of aspirin ( 100 milligram   or 300 milligrams ) and a third have a placebo . The drug ( or placebo ) will be taken day by day for five   years , with follow - up observations in the subsequent   long time . The report is randomise , intend the researchers do n’t take who generate the drug and who catch the dummy tablet . It is also a double - unsighted trial , whereby neither the recommend MD nor the patient know if they are taking the placebo or the aspirin . Randomized controlled trials such as this are the most dependable way to compare treatments .

Dr   Ruth Langley , the   master investigator from the MRC Clinical Trials Unit at University College London , say in astatement : “ There ’s been some interesting research suggesting that aspirin could detain or halt early point cancers coming back , but there ’s been no randomize trial to give exonerated proof . This trial aims to answer this interrogation once and for all . If we find that aspirin does stop these cancers return , it could change next handling – ply a flashy and simple-minded way to assist stop cancer come back and help more masses pull round . ”

Low - dose Empirin is already prescribed daily to many patients , but due to the potential side - effects , researchers want to be certain that the results are worth the risk . This tribulation will hopefully provide an result once and for all .

More information on the tryout can be found on the Add - Aspirin trialpage .